Search research articles
Contact Us
Filters
Showing results (111-120 of 137) with videos related to
Page
of 14
Sort By:
Current Urology Reports
|
April 10, 2025
Management of Patients with Muscle-Invasive Bladder Cancer Achieving A Clinical Complete Response after Neoadjuvant Therapy: Evidence and Consideration for Active Surveillance
Benjamin I Joffe, John R Christin, Clémentine Le Coz, et al.
World Journal of Urology
|
May 11, 2024
Induction and maintenance of sequential intravesical gemcitabine/docetaxel for intermediate and high-risk non-muscle invasive bladder cancer with different dosage protocols
Reuben Ben-David, Neeraja Tillu, Parissa Alerasool, et al.
The Journal of Urology
|
March 3, 2020
A Phase I Trial of Intravesical Cabazitaxel, Gemcitabine and Cisplatin for the Treatment of Nonmuscle Invasive bacillus Calmette-Guérin Unresponsive or Recurrent/Relapsing Urothelial Carcinoma of the Bladder
Guarionex J DeCastro, Wilson Sui, Jamie S Pak, et al.
The Journal of Urology
|
June 15, 2014
Impact of complications and hospital-free days on health related quality of life 1 year after radical cystectomy
Chad R Ritch, Michael S Cookson, Sam S Chang, et al.
Urologic Oncology
|
June 7, 2021
Telemedicine in management of genitourinary malignancies: Patient and physician perspectives
Ezra J Margolin, Luis A Pina Martina, Caleb H Miles, et al.
Seminars in Oncology
|
November 24, 2019
A novel approach to assess real-world efficacy of cancer therapy in metastatic prostate cancer. Analysis of national data on Veterans treated with abiraterone and enzalutamide
Harshraj Leuva, Keith Sigel, Mengxi Zhou, et al.
Science (New York, N.Y.)
|
May 9, 2015
Conservation. Committing to ecological restoration
Katharine Suding, Eric Higgs, Margaret Palmer, et al.
Urologic Oncology
|
June 8, 2025
Combination regimen of intravesical docetaxel, gemcitabine, and cisplatin in patients with BCG-unresponsive bladder cancer: clinical outcomes and genomic correlations
Benjamin I Joffe, John R Christin, Clémentine Le Coz, et al.
Urology Practice
|
July 2, 2024
Reply by Authors
David S Han, Srinath-Reddi Pingle, Lovie M Amolo, et al.
Urology Practice
|
June 24, 2024
Multidisciplinary Development and Implementation of a Trial of Void Algorithm to Standardize and Reduce Indwelling Urethral Catheter Use
David S Han, Srinath-Reddi Pingle, Lovie M Amolo, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 137) with videos related to
Sort By:
Page
of 14
Current Urology Reports
|
April 10, 2025
Management of Patients with Muscle-Invasive Bladder Cancer Achieving A Clinical Complete Response after Neoadjuvant Therapy: Evidence and Consideration for Active Surveillance
Benjamin I Joffe, John R Christin, Clémentine Le Coz, et al.
World Journal of Urology
|
May 11, 2024
Induction and maintenance of sequential intravesical gemcitabine/docetaxel for intermediate and high-risk non-muscle invasive bladder cancer with different dosage protocols
Reuben Ben-David, Neeraja Tillu, Parissa Alerasool, et al.
The Journal of Urology
|
March 3, 2020
A Phase I Trial of Intravesical Cabazitaxel, Gemcitabine and Cisplatin for the Treatment of Nonmuscle Invasive bacillus Calmette-Guérin Unresponsive or Recurrent/Relapsing Urothelial Carcinoma of the Bladder
Guarionex J DeCastro, Wilson Sui, Jamie S Pak, et al.
The Journal of Urology
|
June 15, 2014
Impact of complications and hospital-free days on health related quality of life 1 year after radical cystectomy
Chad R Ritch, Michael S Cookson, Sam S Chang, et al.
Urologic Oncology
|
June 7, 2021
Telemedicine in management of genitourinary malignancies: Patient and physician perspectives
Ezra J Margolin, Luis A Pina Martina, Caleb H Miles, et al.
Seminars in Oncology
|
November 24, 2019
A novel approach to assess real-world efficacy of cancer therapy in metastatic prostate cancer. Analysis of national data on Veterans treated with abiraterone and enzalutamide
Harshraj Leuva, Keith Sigel, Mengxi Zhou, et al.
Science (New York, N.Y.)
|
May 9, 2015
Conservation. Committing to ecological restoration
Katharine Suding, Eric Higgs, Margaret Palmer, et al.
Urologic Oncology
|
June 8, 2025
Combination regimen of intravesical docetaxel, gemcitabine, and cisplatin in patients with BCG-unresponsive bladder cancer: clinical outcomes and genomic correlations
Benjamin I Joffe, John R Christin, Clémentine Le Coz, et al.
Urology Practice
|
July 2, 2024
Reply by Authors
David S Han, Srinath-Reddi Pingle, Lovie M Amolo, et al.
Urology Practice
|
June 24, 2024
Multidisciplinary Development and Implementation of a Trial of Void Algorithm to Standardize and Reduce Indwelling Urethral Catheter Use
David S Han, Srinath-Reddi Pingle, Lovie M Amolo, et al.
Page
of 14